Validate Clinical Study Feasibility with EHR Data Through ENACT

The ENACT (Evolve to Next-Gen Accrual to Clinical Trials) Network is an IT platform that helps clinical investigators by providing access to de-identified EHR data across the CTSA (Clinical and Translational Science Award) consortium. This tool allows researchers to independently explore and validate the feasibility of clinical studies from their desktops. The ENACT Network is available to all researchers across the University of Michigan at no cost through MICHR. Click here to request access.

ENACT facilitates early-stage cohort discovery, real-time testing and refining of study eligibility criteria, and identification of additional sites for multi-site studies. It helps establish the feasibility of clinical protocols for grant applications and IRB submissions. Developed collaboratively by the CTSA consortium members with NIH funding, ENACT increases the likelihood of successful clinical trial recruitment by enabling thorough exploration of patient cohorts and potential sites.

The ENACT Network’s current capabilities include allowing researchers within the CTSA consortium to explore and validate the feasibility of clinical studies from their desktops in real-time. The platform ensures secure and compliant data processes in accordance with regulations such as HIPAA. Researchers can query patient data from 60+ participating sites, including demographics, diagnoses, lab results, and prescribed medications, to determine the availability of suitable candidates for clinical studies.

The use of the ENACT Network is approved by the University of Michigan Medical School Institutional Review Board (IRBMED) and complies with HIPAA requirements for patient confidentiality.

To learn more or use ENACT, visit the ENACT Network